For oral use.
Adults and children over 12 years of age: Gastrointestinal diseases caused by pathogenic bacteria: Traveler's diarrhea: from 600 mg/day (one 200 mg tablet every 8 hours) to 800 mg/day (two 200 mg tablets every 12 hours) for 3 days.
Gastrointestinal diseases sustained by intestinal bacteria: Hepatic encephalopathy: 1,200 mg/day (two 200 mg tablets every 8 hours) for 7-10 days.
Doses maybe modified in quantity and frequency, according to physician's advice.
Diverticular Disease of the colon: 800 mg/day (two 200 mg tablets every 12 hours) for 7-10 days. Repeated monthly treatment is recommended (7-10 days/month).
Small Intestine Bacterial Overgrowth, Irritable Bowel Syndrome and Inflammatory Bowel Disease: 800 mg/day (two 200 mg tablets every 12 hours) to 1200 mg/day (two 200 mg tablets every 8 hours) for 7-14 days.
Doses may be modified in quantity and frequency, according to physician's advice. In cases where repeated courses of treatment are required, cyclic treatments of one week per month are recommended.
The total duration of the intermittent therapy should be determined by the adequacy of the clinical response of the patients.
NORMIX can be administered with or without food.
No dosage adjustment is necessary in patients with hepatic or renal insufficiency.
Pediatric Population: The safety and efficacy of Rifaximin in children younger than 12 years of age have not been established.
Other Services
Country
Account